Suppr超能文献

西替利嗪和非索非那定在皮肤中的24小时活性。

Twenty-four hours of activity of cetirizine and fexofenadine in the skin.

作者信息

Purohit A, Duvernelle C, Melac M, Pauli G, Frossard N

机构信息

Institut National de la Santé et de la Recherche Médicale, H pitaux Universitaires, Strasbourg, France.

出版信息

Ann Allergy Asthma Immunol. 2001 Apr;86(4):387-92. doi: 10.1016/S1081-1206(10)62483-0.

Abstract

BACKGROUND

Cetirizine and fexofenadine, the active metabolite of terfenadine, are powerful and well-tolerated H1 receptor antagonists effective in the treatment of skin and nose atopic diseases.

OBJECTIVE

We have compared the pharmacodynamic activity of the two antihistamines at therapeutic dosages, cetirizine at 10 mg and fexofenadine at 120 mg and 180 mg, on histamine-induced skin reactivity during a 24-hour period after single intake.

METHODS

Twenty-six healthy volunteers participated in a randomized, double-blind, crossover, placebo-controlled study. The areas of wheal and flare induced by histamine (100 mg/mL) administered by prick test were measured at 0, 0.5, 1, 2, 4, 6, 8, 10, 12, and 24 hours postdose. Statistical analysis of the areas under the time-response curves was performed by a Friedman's ANOVA followed by a Wilcoxon test and Bonferroni's correction.

RESULTS

The three active treatments clearly inhibited the wheal and flare areas throughout the 24-hour period compared with placebo. Maximal inhibition occurred at 4 hours postdose. Between 4 and 24 hours postdose, the time course of inhibition by cetirizine differed significantly (P < 0.001) from that by fexofenadine at either dose, which did not differ from each other. At 24 hours, fexofenadine inhibited <40% of the skin reaction, whereas cetirizine reduced 60% of the wheal. The duration of effect, considered as the time for wheal to be inhibited by at least 70%, also significantly favored cetirizine (19 hours) compared with fexofenadine (9.3 and 8.5 hours for 180 and 120 mg, respectively; P < 0.001). Consistency of activity was evaluated by the frequency of total inhibition of the wheal (> or =95%). Consistency was observed in 26 of 26 participants for cetirizine, 21 of 26 for fexofenadine, 180 mg, and 10 of 26 for fexofenadine, 120 mg (P < 0.001), suggesting better consistency for cetirizine. There was no serious adverse event.

CONCLUSIONS

Our study clearly shows better duration of action and consistency of the antihistaminic activity of cetirizine compared with fexofenadine (120 and 180 mg) in the histamine-induced skin reaction during a 24-hour period.

摘要

背景

西替利嗪以及特非那定的活性代谢物非索非那定,都是强效且耐受性良好的H1受体拮抗剂,对治疗皮肤和鼻部的特应性疾病有效。

目的

我们比较了两种抗组胺药在治疗剂量下(西替利嗪10毫克、非索非那定120毫克和180毫克)单次服药后24小时内对组胺诱导的皮肤反应性的药效学活性。

方法

26名健康志愿者参与了一项随机、双盲、交叉、安慰剂对照研究。在给药后0、0.5、1、2、4、6、8、10、12和24小时,测量通过点刺试验给予组胺(100毫克/毫升)所诱发的风团和红晕面积。通过Friedman方差分析,随后进行Wilcoxon检验和Bonferroni校正,对时间 - 反应曲线下的面积进行统计分析。

结果

与安慰剂相比,三种活性治疗在整个24小时期间均明显抑制了风团和红晕面积。最大抑制作用出现在给药后4小时。在给药后4至24小时,西替利嗪的抑制时间进程与两种剂量的非索非那定均有显著差异(P < 0.001),而两种剂量的非索非那定之间无差异。在24小时时,非索非那定抑制的皮肤反应小于40%,而西替利嗪使风团减少了60%。将效应持续时间定义为风团被抑制至少70%的时间,与非索非那定(180毫克和120毫克分别为9.3小时和8.5小时)相比,西替利嗪(19小时)也明显更具优势(P < 0.001)。通过风团完全抑制(≥95%)的频率评估活性的一致性。西替利嗪在26名参与者中有26名观察到一致性,非索非那定180毫克在26名中有21名,非索非那定120毫克在26名中有10名(P < 0.001),表明西替利嗪具有更好的一致性。未发生严重不良事件。

结论

我们的研究清楚地表明,在24小时期间组胺诱导的皮肤反应中,与非索非那定(120毫克和180毫克)相比,西替利嗪的抗组胺活性作用持续时间更长且一致性更好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验